ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GSK Gsk Plc

1,652.00
1.00 (0.06%)
Last Updated: 10:52:05
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.00 0.06% 1,652.00 1,651.50 1,652.50 1,661.50 1,650.00 1,656.50 463,885 10:52:05
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 13.80 67.99B

GlaxoSmithKline PLC Director/PDMR Shareholding (9406M)

12/05/2015 1:12pm

UK Regulatory


Gsk (LSE:GSK)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Gsk Charts.

TIDMGSK

RNS Number : 9406M

GlaxoSmithKline PLC

12 May 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

I give below details of changes in interests in the Ordinary shares of GlaxoSmithKline plc ('GSK') in respect of the under-mentioned Persons Discharging Managerial Responsibilities ('PDMR') on 11 May 2015:

 
 PDMR         GSK Deferred Annual Bonus Plan 
-----------  ------------------------------------- 
 E Walmsley   Exercise of a nil priced option 
               over 12,432 shares and 1,679 shares 
               granted on 9 March 2012, both of 
               which vested on 9 March 2015 under 
               the GSK Deferred Annual Bonus Plan. 
               GSK delivered the net of tax value 
               in shares being 7,478. 
-----------  ------------------------------------- 
 P Vallance   Exercise of a nil priced option 
               over 24,907 shares and 3,363 shares 
               granted on 9 March 2012, both of 
               which vested on 9 March 2015 under 
               the GSK Deferred Annual Bonus Plan. 
               GSK delivered the net of tax value 
               in shares being 14,983. 
-----------  ------------------------------------- 
 C Thomas     Exercise of a nil priced option 
               over 17,986 shares and 2,429 shares 
               granted on 9 March 2012, both of 
               which vested on 9 March 2015 under 
               the GSK Deferred Annual Bonus Plan. 
               GSK delivered the net of tax value 
               in shares being 10,819. 
-----------  ------------------------------------- 
 D Redfern    Exercise of a nil priced option 
               over 14,644 shares and 1,977 shares 
               granted on 9 March 2012, both of 
               which vested on 9 March 2015 under 
               the GSK Deferred Annual Bonus Plan. 
               GSK delivered the net of tax value 
               in shares being 8,809. 
-----------  ------------------------------------- 
 

The fair market value of an Ordinary Share at the point of exercise on 11 May 2015 was GBP14.73.

The Company and the above-mentioned PDMR's were advised of this transaction on 12 May 2015.

This notification relates to a transaction notified in accordance with paragraph 3.1.4R(1)(a) of the Disclosure and Transparency Rules.

V A Whyte

Company Secretary

12 May 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSLLLFFEEFBBBK

1 Year Gsk Chart

1 Year Gsk Chart

1 Month Gsk Chart

1 Month Gsk Chart

Your Recent History

Delayed Upgrade Clock